Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Postural and Gait Dysfunction in Parkinson Disease
NCT01341080Phase 2Completed
- Sponsor
- Rush University Medical Center
- Start
- Dec 2010
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline in Parkinson's disease (PD) (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Berg Balance Scale at 9 weeks. Started Dec 2010; status: completed.
02
Drugs
varenicline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01341080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341080.